The Health Research Authority are inviting people to #StepForward and become a Research Ethics Committee (REC) member.
REC members meet virtually to review exciting new research studies for some of the biggest challenges in health and social care, including cancer, dementia and COVID-19.
It’s important that committees have insight from different perspectives so that we can all trust their decisions. The HRA are particularly looking for people with no healthcare or research experience.
You’ll be provided with regular training and support and it’s a great opportunity to work with people from a range of backgrounds and learn new skills.
You can find out more here. Alternatively, if you have any questions about being on a REC, please get in touch with Suzy Wignall, Clinical Governance Advisor, and Alternate Vice Chair of the West Midlands – Black Country Research Ethics Committee.
Research transparency – HRA response to the Science and Technology Committee
Could you help the Health Research Authority improve the research ethics review?
PGR Member Required – University Research Ethics Committee
NIHR-CRN podcast – Research Ethics Committees










NIHR Insight South West Central Conference 2026 at Bournemouth University
BU PhD student presented at World Drowning Prevention Conference in South Africa
National Research Supervision Recognition: Apply Now & Join the Supporting Workshop on 16 September
3C Event: ECR Network Café – Wednesday 16 September 2-3pm
BU geography student’s undergraduate dissertation published in international journal
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease